MicroRNA profiling of pericardial fluid samples from patients with heart failure

Suvi M Kuosmanen1, Juha Hartikainen2, Mikko Hippeläinen3

  • 1Department of Biotechnology and Molecular Medicine, A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.

Plos One
|March 13, 2015
PubMed
Abstract

Insights

Pericardial fluid contains microRNAs, but their profiles did not distinguish heart failure stages. These microRNAs may mediate local cardiac cell communication.

Area of Science:

  • Cardiovascular Biology
  • Molecular Biology
  • Biomarker Discovery

Background:

  • Intercellular communication is vital for multicellular organisms.
  • MicroRNAs (miRNAs) secreted in exosomes act as paracrine signaling molecules.
  • Cardiovascular diseases involve miRNAs, which are promising biomarkers due to stability.

Purpose of the Study:

  • Investigate the presence of miRNAs in pericardial fluid.
  • Determine if pericardial fluid miRNAs can differentiate cardiovascular pathologies and disease stages.

Main Methods:

  • Collected pericardial fluid from 51 heart failure patients during open-heart surgery.
  • Measured miRNA profiles using quantitative real-time PCR (qPCR) with Exiqon human panels.
  • Detected an average of 256 miRNAs per sample, with 70 consistently present across all samples.

Main Results:

  • Identified the five most abundant miRNAs: miR-21-5p, miR-451a, miR-125b-5p, let-7b-5p, and miR-16-5p.
  • No specific miRNA signatures were found to distinguish cardiovascular pathologies or heart failure stages.
  • Overall miRNA profiles were highly similar across the diverse patient population.

Conclusions:

  • Pericardial fluid miRNA profiles did not correlate with patient clinical features.
  • Several known heart failure marker miRNAs were detected in the pericardial fluid.
  • The observed miRNA profile suggests an active secretory process, indicating a role in paracrine signaling and local cardiac cell crosstalk.

Related Concept Videos